adenosine monophosphate has been researched along with Embolism, Pulmonary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auger, WR; Forfia, PR; Mishra, S; Morewood, GH; Salamanca-Padilla, YY; Ta, J; Toyoda, Y; Vaidya, A | 1 |
| Devi, S; Kar, N; Mohakud, S; Muthuvel, D | 1 |
| Ahmed, M; Begum, SM; Islam, B; Islam, Z | 1 |
| Amini, H; Azhdari Tehrani, H; Haji Aghajani, M; Moradi, O; Pourheidar, E; Rabiei, MM; Sistanizad, M | 1 |
| Blazejczyk, A; Kalchenko, V; Przygodzki, T; Talar, M; Watala, C | 1 |
1 review(s) available for adenosine monophosphate and Embolism, Pulmonary
| Article | Year |
|---|---|
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; COVID-19; Creatine Kinase; Critical Illness; Dexamethasone; Electromyography; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Muscle, Skeletal; Muscular Diseases; Neural Conduction; Pulmonary Embolism; Quadriplegia; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Staphylococcal Infections; Ventilator Weaning | 2021 |
4 other study(ies) available for adenosine monophosphate and Embolism, Pulmonary
| Article | Year |
|---|---|
Cangrelor and Heparin for Pulmonary Thromboendarterectomy in Heparin-Induced Thrombocytopenia.
Topics: Adenosine Monophosphate; Adult; Endarterectomy; Fibrinolytic Agents; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Pulmonary Embolism; Thrombocytopenia | 2020 |
Deep vein thrombosis with pulmonary thromboembolism in a case of severe COVID-19 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Anticoagulants; Antiparasitic Agents; Antiviral Agents; Computed Tomography Angiography; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Doxycycline; Femoral Vein; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Ivermectin; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Popliteal Vein; Pulmonary Embolism; SARS-CoV-2; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Venous Thrombosis | 2021 |
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Aspirin; Blood Platelets; Coronary Artery Disease; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Disseminated Intravascular Coagulation; Drug Combinations; Female; Hospital Mortality; Humans; Hypertension; Iran; Lopinavir; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2021 |
Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Area Under Curve; Blood Platelets; Eptifibatide; Intravital Microscopy; Laser-Doppler Flowmetry; Lung; Male; Mesentery; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Thrombocytopenia | 2016 |